Faculty

Bryan Kestenbaum

Adjunct Professor, Epidemiology
Professor, Medicine - Nephrology

206-685-7343
brk@uw.edu

Education

MD University of Massachusetts, 1995
MS Epidemiology, University of Washington, 2002
BS Microbiology, University of Massachusetts, 1991

Contact

206-685-7343
brk@uw.edu

University of Washington
Office BB1255
Box 359606
Kidney Research Institute (KRI)
325 9th Avenue
Seattle, WA 98104

Research Interests

Dr. Kestenbaum is a Nephrologist and Epidemiologist who studies the metabolic complications of kidney disease. His research group focuses on developing new methods for assessing kidney function, understanding the determinants and consequences of mineral metabolism disturbances, and investigating the impact of uremic toxins on skeletal muscle functioning. Their ongoing work spans large cohort studies to hands-on translational research within the Kidney Research Institute, a clinical and translational unit that houses a critical mass of investigators, study personnel, and staff.

Recent Publications (PubMed)

tubular secretory solute clearance and hiv infection.
(2023 Mar 29)
J Acquir Immune Defic Syndr
Garimella PS, Scherzer R, Kestenbaum BR, Hoofnagle AN, Jotwani V, Gustafson D, Karim R, Sharma A, Cohen M, Dumond J, Abraham A, Estrella M, Shlipak MG, Ix JH

Carotid Artery Stiffness Mechanisms Are Associated With End Organ Damage and All-Cause Mortality: MESA (Multi-Ethnic Study of Atherosclerosis).
(2023 Mar 28)
J Am Heart Assoc
Pewowaruk R, Korcarz C, De Boer I, Kestenbaum B, Heckbert SR, Tedla YG, Gepner AD

Vitamin D Metabolite Ratio and Coronary Artery Calcification in the Multi-Ethnic Study of Atherosclerosis.
(2023 Mar)
Circ Cardiovasc Imaging 16(3): e015055
Ginsberg C, Hoofnagle AN, Katz R, Cheng JH, Hsu S, Budoff MJ, Kado DM, Kestenbaum B, Siscovick DS, Michos ED, Ix JH, de Boer IH

Metabolomic Profiling Identifies New Endogenous Markers of Tubular Secretory Clearance.
(2023 Jan 1)
Kidney360 4(1): 23-31
Granda ML, Prince DK, Fiehn O, Chen Y, Rajabi T, Yeung CK, Hoofnagle AN, Kestenbaum B

High-Density Lipoprotein Lipidomics in Chronic Kidney Disease.
(2023 Mar 1)
Clin Chem 69(3): 273-282
Lidgard B, Hoofnagle AN, Zelnick LR, de Boer IH, Fretts AM, Kestenbaum BR, Lemaitre RN, Robinson-Cohen C, Bansal N

Show complete publication list

In the News

Exercise May Slow Decline in Kidney Function
Journal of the American Society of Nephrology, 12/12/2013